Skip navigation

Dr Simon Bridge

Senior Lecturer

Department: Applied Sciences

Simon Bridge Staffprofile Northumbriauniversity255

Simon is a viral immunologist who has worked in the field of virology and immunology since 1999 and gained considerable experience in academia, industry and the National Health Service. He trained in Immunology & Virology at Bristol University, Liverpool University, and the Liverpool School of Tropical Medicine. His PhD studies were supervised by Dr Tom Blanchard, the primary aim of his research work was to devise heterologous prime-boost-boost vaccines that would provide protection against HIV-1 by eliciting high titres of broadly reactive neutralising antibodies (Bridge et al., 2011a).

Simon returned to Newcastle University in 2006 for his postdoctoral research and worked in the laboratory of Professors Geoffrey Toms and Margaret Bassendine, and Dr Dermot Neely. His research focused on the association of hepatitis C virus (HCV) with very- and low-density lipoproteins (VLDL/LDL) in the blood of infected patient’s and to examine the metabolic factors, which influence this (Felmlee et al., 2010; Bridge et al., 2011b; Sheridan et al., 2012; Sheridan et al., 2014a, Bridge et al., 2015). This work culminated in a clinical trial investigating whether statins and n3 fatty acids reduced viral loads and the quantity of virus associated with LDL (Sheridan et al., 2014b).

In September 2015, Simon was appointed as a Senior Lecturer in Virology and Viral Immunology following a 3 year, Anniversary Research Fellow in the Faculty of Health & Life Sciences at Northumbria University. Simon maintains an active research interest in viral hepatitis and is particularly interested in the role of HCV in triggering atherosclerosis (Bridge et al., 2018). He is also interested in the role of the microbial communities in cardiovascular & pulmonary disease, inflammatory bowel disease and autoimmune liver disease.

Campus Address

Ellison building



Key Publications

  • Please visit the Pure Research Information Portal for further information
  • Revisiting the Elusive Hepatitis C Vaccine, Todryk, S., Bassendine, M., Bridge, S. 2 Feb 2021, In: Vaccines
  • Covid‐19 and co‐morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity?, Bassendine, M., Bridge, S., McCaughan, G., Gorrell, M. 1 Sep 2020, In: Journal of Diabetes
  • Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review, Bassendine, M., Bridge, S. 14 Jan 2020, In: European Journal of Rheumatology
  • The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation, Nelson, A., Stewart, C., Kennedy, N., Lodge, J., Tremelling, M., Probert, C., Parkes, M., Mansfield, J., Smith, D., Hold, G., Lees, C., Bridge, S., Lamb, C. 29 Oct 2020, In: Journal of Crohn's and Colitis
  • SAT-221-Autoantibodies to apolipoprotein A1 (apoA-1): A new prognostic biomarker of HCV infection, Pagano, S., Sheridan, D., Bridge, S., Shawa, I., Cramp, M., Taylor-Robinson, S., Neely, R., Vuilleumier, N., Bassendine, M. Apr 2019, International Liver Congress 2019
  • Temperate bacteriophages from chronic Pseudomonas aeruginosa lung infections show disease-specific changes in host range and modulate antimicrobial susceptibility, Tariq, M., Everest, F., Cowley, L., Wright, R., Holt, G., Ingram, H., Duignan, L., Nelson, A., Lanyon, C., Perry, A., Perry, J., Bourke, S., Brockhurst, M., Bridge, S., de Soyza, A., Smith, D. 27 Aug 2019, In: mSystems
  • Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?, Bridge, S., Pagano, S., Jones, M., Foster, G., Neely, D., Vuilleumier, N., Bassendine, M. 8 Feb 2018, In: Hepatology International
  • Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?, Bridge, S., Pagano, S., Jones, M., Foster, G., Neely, R., Vuilleumier, N., Bassendine, M. Apr 2018, The International Liver Congress 2018
  • Shigatoxin encoding Bacteriophage φ24B modulates bacterial metabolism to raise antimicrobial tolerance, Holt, G., Lodge, J., McCarthy, A., Graham, A., Young, G., Bridge, S., Brown, A., Veses-Garcia, M., Lanyon, C., Sails, A., Allison, H., Smith, D. 1 Mar 2017, In: Scientific Reports
  • Hepatitis C virus and atherosclerosis: A legacy after virologic cure?, Bassendine, M., Nielsen, S., Bridge, S., Felmlee, D., Sheridan, D., Packard, C., Neely, R. 11 Nov 2016, In: Clinics and Research in Hepatology and Gastroenterology

Qualifications

Medicine PhD September 01 2003


a sign in front of a crowd
+

Northumbria Open Days

Open Days are a great way for you to get a feel of the University, the city of Newcastle upon Tyne and the course(s) you are interested in.

Research at Northumbria
+

Research at Northumbria

Research is the life blood of a University and at Northumbria University we pride ourselves on research that makes a difference; research that has application and affects people's lives.

a person sitting at a table
+

Order your prospectus

If you would like to know more about our courses, or life in general as a student at Northumbria, then we can help you.

Latest News and Features

India - we stand with you

As the impact of Covid-19 continues to be felt across the globe, at Northumbria we want to…

More news

Back to top